package com.hartwig.actin.personalization.datamodel

enum class TreatmentName(val category: TreatmentCategory) {
    EXTERNAL_RADIOTHERAPY_WITH_SENSITIZER(TreatmentCategory.CHEMORADIATION),
    INTENSIVE_CHEMOTHERAPY(TreatmentCategory.CHEMOTHERAPY),
    SYSTEMIC_CHEMOTHERAPY(TreatmentCategory.CHEMOTHERAPY),
    TAXANE_CONTAINING_CHEMOTHERAPY(TreatmentCategory.CHEMOTHERAPY),
    PLATINUM_CONTAINING_CHEMOTHERAPY(TreatmentCategory.CHEMOTHERAPY),
    ANTHRACYCLINE_CONTAINING_CHEMOTHERAPY(TreatmentCategory.CHEMOTHERAPY),
    ANTHRACYCLINE_AND_TAXANE_CONTAINING_CHEMOTHERAPY(TreatmentCategory.CHEMOTHERAPY),
    CHEMOTHERAPY_ABROAD(TreatmentCategory.CHEMOTHERAPY),
    CYCLOPHOSPHAMIDE(TreatmentCategory.CHEMOTHERAPY),
    CHLORAMBUCIL_LEUKERAN(TreatmentCategory.CHEMOTHERAPY),
    MELPHALAN(TreatmentCategory.CHEMOTHERAPY),
    BENDAMUSTINE(TreatmentCategory.CHEMOTHERAPY),
    METHOTREXATE(TreatmentCategory.CHEMOTHERAPY),
    RALTITREXED(TreatmentCategory.CHEMOTHERAPY),
    PEMETREXED(TreatmentCategory.CHEMOTHERAPY),
    CLADRIBINE(TreatmentCategory.CHEMOTHERAPY),
    CYTARABINE(TreatmentCategory.CHEMOTHERAPY),
    FLUOROURACIL(TreatmentCategory.CHEMOTHERAPY),
    TEGAFUR(TreatmentCategory.CHEMOTHERAPY),
    GEMCITABINE_SYSTEMIC(TreatmentCategory.CHEMOTHERAPY),
    CAPECITABINE(TreatmentCategory.CHEMOTHERAPY),
    TEGAFUR_GIMERACIL_OTERACIL(TreatmentCategory.CHEMOTHERAPY),
    TRIFLURIDINE_TIPIRACIL(TreatmentCategory.CHEMOTHERAPY),
    VINCRISTINE(TreatmentCategory.CHEMOTHERAPY),
    ETOPOSIDE(TreatmentCategory.CHEMOTHERAPY),
    PACLITAXEL(TreatmentCategory.CHEMOTHERAPY),
    DOCETAXEL(TreatmentCategory.CHEMOTHERAPY),
    IRINOTECAN(TreatmentCategory.CHEMOTHERAPY),
    DOXORUBICIN_ADRIAMYCIN(TreatmentCategory.CHEMOTHERAPY),
    DAUNORUBICIN(TreatmentCategory.CHEMOTHERAPY),
    EPIRUBICIN_SYSTEMIC(TreatmentCategory.CHEMOTHERAPY),
    MITOMYCIN_SYSTEMIC(TreatmentCategory.CHEMOTHERAPY),
    CISPLATIN(TreatmentCategory.CHEMOTHERAPY),
    CARBOPLATIN(TreatmentCategory.CHEMOTHERAPY),
    OXALIPLATIN(TreatmentCategory.CHEMOTHERAPY),
    HYDROREA_HYDROXYUREA(TreatmentCategory.CHEMOTHERAPY),
    ATO_ARSENIC_TRIOXIDE(TreatmentCategory.CHEMOTHERAPY),
    HORMONAL_THERAPY_NNO(TreatmentCategory.HORMONAL_THERAPY),
    HORMONAL_THERAPY_THROUGH_SURGERY(TreatmentCategory.HORMONAL_THERAPY),
    DRUG_HORMONAL_THERAPY(TreatmentCategory.HORMONAL_THERAPY),
    OCTREOTIDE(TreatmentCategory.HORMONAL_THERAPY),
    MEGESTROL_MEGACE(TreatmentCategory.HORMONAL_THERAPY),
    GONADORELIN_AGONISTS_LHRH(TreatmentCategory.HORMONAL_THERAPY),
    LEUPRORELIN_ELIGARD_LUCRIN(TreatmentCategory.HORMONAL_THERAPY),
    GOSERELIN_ZOLADEX(TreatmentCategory.HORMONAL_THERAPY),
    TRIPTORELIN_PAMORELIN(TreatmentCategory.HORMONAL_THERAPY),
    TAMOXIFEN(TreatmentCategory.HORMONAL_THERAPY),
    ANTI_ANDROGENS(TreatmentCategory.HORMONAL_THERAPY),
    BICALUTAMIDE_BILURON_CASODEX(TreatmentCategory.HORMONAL_THERAPY),
    AROMATASE_INHIBITORS(TreatmentCategory.HORMONAL_THERAPY),
    ANASTROZOLE(TreatmentCategory.HORMONAL_THERAPY),
    LETROZOLE_FEMARA(TreatmentCategory.HORMONAL_THERAPY),
    GONADORELIN_ANTAGONISTS_LHRH(TreatmentCategory.HORMONAL_THERAPY),
    ABIRATERONE_ZYTIGA_AND_PREDNISONE(TreatmentCategory.HORMONAL_THERAPY),
    DEXAMETHASONE(TreatmentCategory.OTHER_TREATMENTS),
    PREDNISONE(TreatmentCategory.OTHER_TREATMENTS),
    INTERFERON_ALPHA_2A(TreatmentCategory.OTHER_TREATMENTS),
    TARGETED_THERAPY(TreatmentCategory.TARGETED_THERAPY),
    ANGIOGENESIS_INHIBITOR(TreatmentCategory.TARGETED_THERAPY),
    TARGETED_THERAPY_ABROAD(TreatmentCategory.TARGETED_THERAPY),
    STUDY_MEDICATION_IMMUNOTHERAPY(TreatmentCategory.TARGETED_THERAPY),
    PROTEIN_KINASE_INHIBITORS(TreatmentCategory.TARGETED_THERAPY),
    IMATINIB(TreatmentCategory.TARGETED_THERAPY),
    ERLOTINIB(TreatmentCategory.TARGETED_THERAPY),
    VEMURAFENIB(TreatmentCategory.TARGETED_THERAPY),
    DABRAFENIB(TreatmentCategory.TARGETED_THERAPY),
    ENCORAFENIB(TreatmentCategory.TARGETED_THERAPY),
    TRAMETINIB(TreatmentCategory.TARGETED_THERAPY),
    BINIMETINIB(TreatmentCategory.TARGETED_THERAPY),
    RUXOLITINIB(TreatmentCategory.TARGETED_THERAPY),
    AXITINIB(TreatmentCategory.TARGETED_THERAPY),
    IBRUTINIB(TreatmentCategory.TARGETED_THERAPY),
    PAZOPANIB(TreatmentCategory.TARGETED_THERAPY),
    CABOZANTINIB(TreatmentCategory.TARGETED_THERAPY),
    MONOCLONAL_ANTIBODIES(TreatmentCategory.TARGETED_THERAPY),
    RITUXIMAB(TreatmentCategory.TARGETED_THERAPY),
    TRASTUZUMAB_HERCEPTIN(TreatmentCategory.TARGETED_THERAPY),
    PERTUZUMAB(TreatmentCategory.TARGETED_THERAPY),
    CETUXIMAB(TreatmentCategory.TARGETED_THERAPY),
    PANITUMUMAB(TreatmentCategory.TARGETED_THERAPY),
    NIVOLUMAB(TreatmentCategory.TARGETED_THERAPY),
    PEMBROLIZUMAB(TreatmentCategory.TARGETED_THERAPY),
    DURVALUMAB(TreatmentCategory.TARGETED_THERAPY),
    ATEZOLIZUMAB(TreatmentCategory.TARGETED_THERAPY),
    BEVACIZUMAB(TreatmentCategory.TARGETED_THERAPY),
    IPILIMUMAB(TreatmentCategory.TARGETED_THERAPY),
    TREMELIMUMAB(TreatmentCategory.TARGETED_THERAPY),
    BORTEZOMIB(TreatmentCategory.TARGETED_THERAPY),
    THALIDOMIDE(TreatmentCategory.TARGETED_THERAPY),
    LENALIDOMIDE(TreatmentCategory.TARGETED_THERAPY),
}